Search results
Results from the WOW.Com Content Network
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules). It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs. The list is designated within the Controlled ...
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug or other substances may lead to severe psychological or physical dependence. The complete list of Schedule II substances is as follows.
The DEA Rocky Mountain Field Division said 10 of Colorado’s worst drug criminals were arrested under "Operation Return to Sender" and handed over to immigration enforcement. Their efforts have ...
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The DEA has found pill presses, punches and other substances that can be used to make fake pills containing fentanyl are being offered for sale on various platforms. In 2023, the DEA seized over ...
For premium support please call: 800-290-4726 more ways to reach us
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The deepening crisis in Haiti is not occurring in isolation and is linked to the broader Caribbean problem in which illicit firearms and drugs are a growing concern, the U.N. drug office says.